R&D often requires a minimum scale and the costs are relatively fixed while the benefits vary with output. This can achieve economies of scale for firms as they grow larger e.g. Apple.
Below is a diagram to show the level of R&D expenditure into UK businesses from the period 2009-13. This diagram shows that the pharmaceuticals industry appears to be the biggest recipient of R&D due to its heavy research into new drugs for medical use.
